High Court Seeks SG's Input On Generic-Drug Liability
The U.S. Supreme Court on Monday asked the solicitor general to weigh in on whether generic-drug makers can be held liable for providing allegedly inadequate warnings on product labels, a scenario...To view the full article, register now.
Already a subscriber? Click here to view full article